Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

Di Staso, Rossana; Casadei, Beatrice; Locke, Frederick; Voorhees, Timothy; Kittai, Adam; Jain, Michael; Barba, Pere; IACOBONI, GLORIA

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Di Staso, Rossana
dc.contributor.author	Casadei, Beatrice
dc.contributor.author	Locke, Frederick
dc.contributor.author	Voorhees, Timothy
dc.contributor.author	Kittai, Adam
dc.contributor.author	Jain, Michael
dc.contributor.author	Barba, Pere
dc.contributor.author	IACOBONI, GLORIA
dc.date.accessioned	2025-01-20T10:08:02Z
dc.date.available	2025-01-20T10:08:02Z
dc.date.issued	2024-11-07
dc.identifier.citation	Di Staso R, Casadei B, Locke FL, Jain M, Voorhees TJ, Kittai AS, et al. Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma. Blood Cancer J. 2024 Nov 7;14:197.
dc.identifier.issn	2044-5385
dc.identifier.uri	https://hdl.handle.net/11351/12439
dc.description	Células CAR-T; Linfoma difuso de células B grandes
dc.language.iso	eng
dc.publisher	Springer Nature
dc.relation.ispartofseries	Blood Cancer Journal;14
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Cèl·lules T
dc.subject	Cèl·lules B - Tumors - Immunoteràpia
dc.subject.mesh	Immunotherapy, Adoptive
dc.subject.mesh	Lymphoma, Large B-Cell, Diffuse
dc.subject.mesh	/drug therapy
dc.title	Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41408-024-01183-8
dc.subject.decs	inmunoterapia adoptiva
dc.subject.decs	linfoma de células B grandes difuso
dc.subject.decs	/farmacoterapia
dc.relation.publishversion	https://doi.org/10.1038/s41408-024-01183-8
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Di Staso R] Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. [Casadei B] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy. [Locke FL, Jain M] Moffitt Cancer Center, Tampa, FL, USA. [Voorhees TJ, Kittai AS] Division of Hematology, The Ohio State University, Columbus, OH, USA. [Iacoboni G, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid	39511146
dc.identifier.wos	001352378700002
dc.rights.accessrights	info:eu-repo/semantics/openAccess